# Anthrax Vaccine Clinical Trials

> **NCT00114621** · PHASE1 · COMPLETED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 93 (actual)

## Conditions studied

- Anthrax

## Interventions

- **DRUG:** Anthrax Vaccine
- **PROCEDURE:** Blood Chemistry
- **PROCEDURE:** Hematology
- **PROCEDURE:** Urinalysis

## Key facts

- **NCT ID:** NCT00114621
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09-08
- **Primary completion:** —
- **Final completion:** 2011-05-25
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114621, "Anthrax Vaccine Clinical Trials". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00114621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*